Latest Strategy Changes News

Anagenics Limited reported a cash outflow of $424K for Q3 2025 but maintains robust liquidity with $1.48 million in available funding, supported by a mix of secured and unsecured loans.

Sparc Technologies has successfully raised up to A$2.7 million through a share placement and a Share Purchase Plan, positioning the company to accelerate commercialisation of its graphene additive ecosparc and support its green hydrogen pilot projects.

AdAlta Limited has announced a renounceable rights issue to raise up to $1.3 million, aiming to accelerate its ‘East to West’ cellular immunotherapy strategy and explore new strategic options.

Dreadnought Resources has partnered with Teck Resources in a $15 million farm-in and joint venture to advance the Money Intrusion Ni-Cu-Co-PGE prospect at Mangaroon, WA. This deal brings a major global player into the project, accelerating exploration while preserving Dreadnought’s gold ambitions.

Blackstone Minerals and IDM International have reported impressive assay results from drillhole CDH-61 at the Mankayan copper-gold porphyry project, confirming over 300 metres of high-grade mineralisation and a robust high-grade core. This milestone reinforces Mankayan's status as a world-class undeveloped copper-gold asset with significant development optionality.

GPT Group unveiled a strategic pivot towards co-investment alongside capital partners, reporting resilient 2024 earnings and expanding its retail management platform through key partnerships and asset acquisitions.

Perpetual Resources has appointed ServDrill Brazil to begin its inaugural lithium drilling campaign at the promising Igrejinha Project in Brazil’s Lithium Valley, targeting high-grade spodumene mineralisation along a 1.4km pegmatite corridor.

Rewardle Holdings reported a strong March quarter with positive operational cash flow of $1.36 million, driven by its strategic partnership with MedTech firm CloudHolter, while progressing towards ASX relisting.

RareX Limited has won a $175,000 government-backed drilling grant to advance exploration of significant gallium mineralisation at its Khaleesi Project in Western Australia, underpinning the project’s critical minerals promise.

Dimerix has inked an exclusive US licensing agreement with Amicus Therapeutics for DMX-200, a promising Phase 3 treatment for FSGS, unlocking $30 million upfront and up to $560 million in milestones.

Assetora Limited has dramatically reduced its net liabilities and strengthened its balance sheet through strategic capital raises and debt conversions, while unveiling a comprehensive rebrand and leadership expansion to drive its next growth phase.

Baby Bunting Group unveils its ambitious ‘Store of the Future’ strategy, targeting a return to double-digit EBITDA margins through store refurbishments, new small format pilots, and enhanced omni-channel capabilities. The company sets FY25 NPAT guidance between $10 million and $12.5 million, underpinned by a 40% gross margin target.